LABAER JOSHUA has a total of 13 patent applications. Its first patent ever was published in 2004. It filed its patents most often in United States and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets measurement, biotechnology and organic fine chemistry are SHANGHAI INST FOR FOOD AND DRUG CONTROL, MARLIGEN BIOSCIENCES INC and BIONANO HEALTH GUARD RES CENTER.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 11 | |
#2 | WIPO (World Intellectual Property Organization) | 2 |
# | Industry | |
---|---|---|
#1 | Measurement | |
#2 | Biotechnology | |
#3 | Organic fine chemistry | |
#4 | Environmental technology |
# | Technology | |
---|---|---|
#1 | Analysing materials | |
#2 | Measuring microorganism processes | |
#3 | Peptides | |
#4 | Microorganisms | |
#5 | Combinatorial chemistry | |
#6 | Climate change adaptation technologies |
# | Name | Total Patents |
---|---|---|
#1 | Labaer Joshua | 13 |
#2 | Ramachandran Niroshan | 4 |
#3 | Qiu Ji | 4 |
#4 | Garcia Manuel Fuentes | 2 |
#5 | Schatz Desmond A | 2 |
#6 | Bian Xiaofang | 2 |
#7 | Wallstrom Garrick | 2 |
#8 | Wasserfall Clive H | 2 |
#9 | Atkinson Mark A | 2 |
#10 | Song Lusheng | 2 |
Publication | Filing date | Title |
---|---|---|
WO2021081296A1 | Novel antibodies for detecting epstein barr virus-positive gastric cancer | |
WO2021062041A1 | Novel antibodies for detecting gastric cancer | |
US2016195546A1 | Type 1 Diabetes Biomarkers | |
US2016083793A1 | Radiation biodosimetry systems | |
US2016122751A1 | Nucleic acid-tagged compositions and methods for multiplexed protein-protein interaction profiling | |
US2014162902A1 | Cell-Based Materials and Methods for Defining Pharmacogenetic Differences in Drug Metabolism | |
US2008071071A1 | Evaluating proteins |